Journal of Medicinal Chemistry · 2016 · 14 citations · 31 references
MedicineMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryNeuropharmacologyFunctional Group SubstitutionGlutamatergic PharmacologyLigand BindingNeurotransmissionNeurotransmitter ReceptorsSynaptic TransmissionAgonist ActivityCore Scaffold LibrariesGlutamate NeurotransmissionGlutamatergic NeurotransmissionGlutamatergic Transmission ModulationMetabotropic ReceptorsPharmacology Of Glutamate ReceptorsStereoselective Synthesis
The metabotropic glutamate (Glu) receptors (mGluRs) play key roles in modulating excitatory neurotransmission in the brain. In all, eight subtypes have been identified and divided into three groups, group I (mGlu1,5), group II (mGlu2,3), and group III (mGlu4,6-8). In this article, we present a L-2,4-syn-substituted Glu analogue, 1d, which displays selective agonist activity at mGlu2 over the remaining mGluR subtypes. A modeling study and redesign of the core scaffold led to the stereoselective synthesis of four new conformationally restricted Glu analogues, 2a-d. Most interestingly, 2a retained a selective agonist activity profile at mGlu2 (EC50 in the micromolar range), whereas 2c/2d were both selective agonists at group III, subtypes mGlu4,6,8. In general, 2d was 20-fold more potent than 2c and potently activated mGlu4,6,8 in the low-mid nanomolar range.
31
Glutamate-Dependent Neuroglial Calcium Signaling Differs Between Young and Adult Brain
Wei Sun, Evan McConnell, Jean‐François Paré et al. · Science · 2013 · 516 citations
James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1997 · 393 citations
Valeria Bruno, Francesc X. Sureda, Marianna Storto et al. · Journal of Neuroscience · 1997 · 147 citations · Full text
Medicine, Neurobiology, Neuroscience +17